Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jan 03, 2017 $53.25 $54.30 $51.45 $54.15 144 905
Dec 30, 2016 $53.25 $54.15 $52.50 $53.10 92 398
Dec 29, 2016 $53.70 $54.60 $52.80 $53.40 78 744
Dec 28, 2016 $54.00 $54.90 $52.95 $53.70 101 844
Dec 27, 2016 $56.10 $57.00 $54.15 $54.30 101 152
Dec 23, 2016 $54.15 $56.55 $54.15 $56.40 103 123
Dec 22, 2016 $57.00 $57.00 $53.55 $54.15 95 578
Dec 21, 2016 $58.05 $58.65 $56.55 $56.85 68 742
Dec 20, 2016 $58.80 $60.30 $57.60 $58.35 72 629
Dec 19, 2016 $57.60 $61.05 $57.30 $58.50 150 855
Dec 16, 2016 $56.25 $58.50 $55.80 $57.45 179 671
Dec 15, 2016 $56.40 $56.70 $55.26 $56.25 116 905
Dec 14, 2016 $56.55 $56.70 $54.60 $55.80 111 905
Dec 13, 2016 $55.35 $56.85 $54.30 $56.25 105 753
Dec 12, 2016 $55.50 $56.70 $54.45 $56.10 107 536
Dec 09, 2016 $56.70 $58.35 $55.80 $56.25 107 096
Dec 08, 2016 $55.50 $56.70 $54.15 $56.10 122 571
Dec 07, 2016 $57.90 $58.65 $54.45 $56.40 160 175
Dec 06, 2016 $57.75 $59.55 $55.50 $59.25 125 098
Dec 05, 2016 $54.30 $57.90 $53.25 $56.85 127 319
Dec 02, 2016 $53.10 $55.95 $52.65 $53.25 120 591
Dec 01, 2016 $57.60 $57.75 $52.80 $53.55 223 948
Nov 30, 2016 $60.30 $61.65 $56.40 $57.15 138 868
Nov 29, 2016 $59.10 $61.80 $57.60 $60.30 129 394
Nov 28, 2016 $66.45 $67.20 $58.50 $58.65 212 272
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT